drugset / Trial / NCT00453765

The Effect of Montelukast in Patients With Chronic Cough and Bronchial Hyperreactivity

NCT00453765

Phase 4 Completed 89 enrolled Isala
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose is to determine whether montelukast during 6 weeks has superior antitussive effects (measured with the LCQ) compared with placebo in patients with cough lasting \> 8 weeks and enhanced bronchial hyperreactivity.

Timeline

Start
2007-12
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg